HomeNDC LookupRxCUI directory › RxCUI 856940

Acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution — RxCUI 856940

RxNorm drug concept · Semantic clinical drug
RxCUI 856940 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 12 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI856940
Official nameAcetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asAPAP 21.7 MG/ML / Hydrocodone Bitartrate 0.5 MG/ML Oral Solution; HYDROcodone bitartrate 7.5 MG / acetaminophen 325 MG in 15 mL Oral Solution; acetaminophen 108 MG / hydrocodone bitartrate 2.5 MG per 5 ML Oral Solution; acetaminophen 217 MG / hydrocodone bitartrate 5 MG per 10 ML Oral Solution; acetaminophen 325 MG / hydrocodone bitartrate 7.5 MG per 15 ML Oral Solution
FDA products mapped10
Package NDCs mapped12
Reported Medicaid activity (SDUD)83,844 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Acetaminophen Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. The IV form is used when you can't take medication by mouth — for example, after surgery, if you're nauseated, or if you need faster, more reliable absorption. It d...
  • Why am I getting acetaminophen through an IV instead of just taking a pill?
  • Yes, Acetaminophen Injection is approved for children — for pain relief in kids 2 years and older, and for fever reduction in patients of all ages, including premature newborns bor...
  • The most important things to watch for are signs of a serious allergic reaction — swelling of your face, mouth, or throat, trouble breathing, or hives — and any new skin rash. Eith...
📖 Read our full Acetaminophen Injection guide →

🕸️ Concept Web — How Acetaminophen 21.7 MG/ML / hydrocodone bitartrat... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution RxCUI 856940

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Acetaminophen 161
    • Hydrocodone 5489
    • Acetaminophen / hydrocodone 214182
    • Hydrocodone bitartrate 142439
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hycet 542941
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Acetaminophen / hydrocodone Oral Solution 370759
    • Acetaminophen / hydrocodone bitartrate Oral Solution 2646966
    • Acetaminophen / hydrocodone Oral Liquid Product 1151548
    • Acetaminophen / hydrocodone Oral Product 1151549
    • Acetaminophen / hydrocodone bitartrate Oral Liquid Product 2663318
    • Acetaminophen / hydrocodone bitartrate Oral Product 2661100
    • Acetaminophen / hydrocodone Oral Solution [Hycet] 542943
    • Acetaminophen / hydrocodone bitartrate Oral Solution [Hycet] 2654206
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Acetaminophen 21.7 MG/ML 332581
    • Hydrocodone bitartrate 0.5 MG/ML 856939
    • Acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Hycet] 856942
    • Acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML [Hycet] 856941

Showing up to 8 concepts per family — 17 of 22 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Acetaminophen 21.7 MG/ML SCDC · 332581
  • Hydrocodone bitartrate 0.5 MG/ML SCDC · 856939
  • Acetaminophen / hydrocodone Oral Solution SCDF · 370759
  • Acetaminophen / hydrocodone bitartrate Oral Solution SCDFP · 2646966
  • Acetaminophen / hydrocodone Oral Liquid Product SCDG · 1151548
  • Acetaminophen / hydrocodone Oral Product SCDG · 1151549
  • Acetaminophen / hydrocodone bitartrate Oral Liquid Product SCDGP · 2663318
  • Acetaminophen / hydrocodone bitartrate Oral Product SCDGP · 2661100

Brand-Name Concepts

  • Acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Hycet] SBD · 856942
  • Acetaminophen 21.7 MG/ML / hydrocodone bitartrate 0.5 MG/ML [Hycet] SBDC · 856941
  • Acetaminophen / hydrocodone Oral Solution [Hycet] SBDF · 542943
  • Acetaminophen / hydrocodone bitartrate Oral Solution [Hycet] SBDFP · 2654206
  • Hycet Oral Liquid Product SBDG · 1172717
  • Hycet Oral Product SBDG · 1172718
  • Hycet BN · 542941

📦 FDA Products & Package NDCs

10 products · 12 package NDCs
12 package NDCs map to RxCUI 856940 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00121-1544-40 4 TRAY in 1 CASE (0121-1544-40) / 10 CUP, UNIT-DOSE in 1 TR... Hydrocodone Bitartrate and Acetaminophen PAI Holdings, LLC dba PAI Pharma 2013-07-29
00121-2316-50 5 TRAY in 1 CASE (0121-2316-50) / 10 CUP, UNIT-DOSE in 1 TR... Hydrocodone Bitartrate and Acetaminophen PAI Holdings, LLC dba PAI Pharma 2020-05-21
00121-4772-40 4 TRAY in 1 CASE (0121-4772-40) / 10 CUP, UNIT-DOSE in 1 TR... Hydrocodone Bitartrate and Acetaminophen PAI Holdings, LLC dba PAI Pharma 2013-07-29
27808-0049-01 473 mL in 1 BOTTLE, PLASTIC (27808-049-01) Hydrocodone Bitartrate and Acetaminophen Cranbury Pharmaceuticals, LLC 2022-12-30
60687-0417-71 5 TRAY in 1 CASE (60687-417-71) / 10 CUP, UNIT-DOSE in 1 TR... Hydrocodone Bitartrate and Acetaminophen American Health Packaging 2019-06-19
64950-0343-11 118 mL in 1 BOTTLE (64950-343-11) Hydrocodone Bitartrate and Acetaminophen Genus Lifesciences Inc. 2020-06-20
64950-0343-16 473 mL in 1 BOTTLE (64950-343-16) Hydrocodone Bitartrate and Acetaminophen Genus Lifesciences Inc. 2020-06-20
64950-0373-04 4 mL in 1 BOTTLE (64950-373-04) Hydrocodone Bitartrate and Acetaminophen Genus Lifesciences Inc. 2023-10-15
64950-0373-16 473 mL in 1 BOTTLE (64950-373-16) Hydrocodone Bitartrate and Acetaminophen Genus Lifesciences Inc. 2023-10-15
67296-2093-01 118 mL in 1 BOTTLE (67296-2093-1) Hydrocodone Bitartrate and Acetaminophen Redpharm drug 2023-10-15
67296-2166-01 118 mL in 1 BOTTLE (67296-2166-1) Hydrocodone Bitartrate and Acetaminophen Redpharm Drug 2019-04-08
71930-0027-43 473 mL in 1 BOTTLE (71930-027-43) Hydrocodone Bitartrate and Acetaminophen Eywa Pharma Inc 2019-04-08
Observed labelers: Genus Lifesciences Inc. (4) · PAI Holdings, LLC dba PAI Pharma (3) · Redpharm Drug (2) · American Health Packaging (1) · Cranbury Pharmaceuticals, LLC (1) · Eywa Pharma Inc (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.